US President Donald Trump has imposed a 25 % tariff on Canada’s steel and aluminium and has threatened sweeping tariffs on ...

Research analysts at William Blair upped their FY2025 EPS estimates for shares of ABM Industries in a report issued on ...

William Blair reaffirmed their market perform rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report ...

William Blair lifted their Q1 2026 earnings estimates for shares of Ionis Pharmaceuticals in a research note issued on ...

Equities research analysts at William Blair issued their FY2029 earnings per share (EPS) estimates for shares of Genmab A/S ...

Stock analysts at William Blair lowered their FY2026 earnings estimates for Ferguson in a research report issued on Tuesday, ...

William Blair cut their Q2 2026 earnings per share estimates for shares of Oracle in a report issued on Tuesday, March 11th.

Investment analysts at William Blair lowered their FY2025 earnings per share (EPS) estimates for Oracle in a note issued to ...

William Blair downgraded shares of Udemy (NASDAQ:UDMY – Free Report) from an outperform rating to a market perform rating in ...

Fintel reports that on March 12, 2025, William Blair downgraded their outlook for Udemy (NasdaqGS:UDMY) from Outperform to ...

Equities research analysts at William Blair lowered their FY2025 earnings per share estimates for shares of Zealand Pharma A/S in a research note issued to investors on Wednesday, March 12th. William ...

Stock analysts at William Blair issued their FY2026 EPS estimates for Exagen in a research note issued to investors on ...